RU2612557C2 - Амидное производное и его применение в качестве критерия стабильности фармацевтической композиции луликоназола - Google Patents

Амидное производное и его применение в качестве критерия стабильности фармацевтической композиции луликоназола Download PDF

Info

Publication number
RU2612557C2
RU2612557C2 RU2015113587A RU2015113587A RU2612557C2 RU 2612557 C2 RU2612557 C2 RU 2612557C2 RU 2015113587 A RU2015113587 A RU 2015113587A RU 2015113587 A RU2015113587 A RU 2015113587A RU 2612557 C2 RU2612557 C2 RU 2612557C2
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
luliconazole
amide derivative
component
amount
Prior art date
Application number
RU2015113587A
Other languages
English (en)
Russian (ru)
Other versions
RU2015113587A (ru
Inventor
Такааки МАСУДА
Хироси ЯМАГУТИ
Original Assignee
Пола Фарма Инк.
Нихон Нохияку Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пола Фарма Инк., Нихон Нохияку Ко., Лтд. filed Critical Пола Фарма Инк.
Publication of RU2015113587A publication Critical patent/RU2015113587A/ru
Application granted granted Critical
Publication of RU2612557C2 publication Critical patent/RU2612557C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
RU2015113587A 2012-09-14 2013-02-19 Амидное производное и его применение в качестве критерия стабильности фармацевтической композиции луликоназола RU2612557C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012202696A JP5460797B1 (ja) 2012-09-14 2012-09-14 アミド誘導体及び安定性指標としてのその使用
JP2012-202696 2012-09-14
PCT/JP2013/055025 WO2014041825A1 (en) 2012-09-14 2013-02-19 Amide derivative and use of the same as stability index of a luliconazole pharmaceutical formulation

Publications (2)

Publication Number Publication Date
RU2015113587A RU2015113587A (ru) 2016-11-10
RU2612557C2 true RU2612557C2 (ru) 2017-03-09

Family

ID=47884458

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015113587A RU2612557C2 (ru) 2012-09-14 2013-02-19 Амидное производное и его применение в качестве критерия стабильности фармацевтической композиции луликоназола

Country Status (7)

Country Link
US (1) US9145401B2 (enExample)
EP (1) EP2895480A1 (enExample)
JP (1) JP5460797B1 (enExample)
CN (1) CN104662017A (enExample)
IN (1) IN2015DN02930A (enExample)
RU (1) RU2612557C2 (enExample)
WO (1) WO2014041825A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2847436C2 (ru) * 2022-03-18 2025-10-03 Нихон Нохияку Ко., Лтд. Соединение азола и противогрибковый агент

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2416758B8 (en) 2009-04-09 2017-10-18 Pola Pharma Inc. Antimycotic pharmaceutical composition
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
WO2011024620A1 (en) 2009-08-25 2011-03-03 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP5832451B2 (ja) 2010-06-11 2015-12-16 株式会社ポーラファルマ 抗真菌医薬組成物
US9068958B1 (en) 2012-09-14 2015-06-30 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and pharmaceutical composition prepared by containing the crystal
WO2014041708A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal
CN104284662A (zh) 2012-09-14 2015-01-14 宝丽制药股份有限公司 晶体及包含该晶体的药物制剂
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5680161B1 (ja) 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) * 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
JP5926756B2 (ja) * 2014-03-26 2016-05-25 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
JP5623671B1 (ja) * 2014-07-23 2014-11-12 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
EP3230280A4 (en) * 2014-12-12 2018-05-09 Glenmark Pharmaceuticals Limited Process for preparation of luliconazole
US12270740B2 (en) * 2019-02-07 2025-04-08 Shimadzu Corporation Analysis method, analysis device and non-transitory computer readable recording medium storing program

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010093992A1 (en) * 2009-02-13 2010-08-19 Topica Pharmaceuticals, Inc Anti-fungal formulation
RU2423128C2 (ru) * 2006-03-08 2011-07-10 Нихон Нохияку Ко., Лтд. Фармацевтическая композиция для наружного применения
WO2011155640A1 (en) * 2010-06-11 2011-12-15 Pola Pharma Inc. Antimycotic pharmaceutical composition

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3081766B2 (ja) 1994-05-06 2000-08-28 東興薬品工業株式会社 角質貯留型抗真菌外用組成物
WO1997002821A2 (en) 1995-07-08 1997-01-30 Nihon Nohyaku Co., Ltd. Antifungal agent, compound therefor, process for producing the same
JP2002114680A (ja) 2000-07-31 2002-04-16 Nippon Nohyaku Co Ltd 抗真菌剤
AU2006339841B2 (en) 2006-03-08 2012-08-30 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
US8058303B2 (en) 2006-03-08 2011-11-15 Nihon Nohyaku Co, Ltd Pharmaceutical composition for external use
JP5529539B2 (ja) 2007-09-05 2014-06-25 株式会社ポーラファルマ 医薬組成物
JP5345937B2 (ja) 2007-09-05 2013-11-20 株式会社ポーラファルマ 抗真菌組成物
JP5453093B2 (ja) 2007-09-05 2014-03-26 株式会社ポーラファルマ 抗真菌医薬組成物
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2416758B8 (en) 2009-04-09 2017-10-18 Pola Pharma Inc. Antimycotic pharmaceutical composition
WO2011024620A1 (en) 2009-08-25 2011-03-03 Pola Pharma Inc. Antimycotic pharmaceutical composition
WO2014041708A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal
US9068958B1 (en) 2012-09-14 2015-06-30 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and pharmaceutical composition prepared by containing the crystal
CN104284662A (zh) 2012-09-14 2015-01-14 宝丽制药股份有限公司 晶体及包含该晶体的药物制剂
EP2895164A1 (en) * 2012-09-14 2015-07-22 Pola Pharma Inc. Pharmaceutical composition containing luliconazole
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) * 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2423128C2 (ru) * 2006-03-08 2011-07-10 Нихон Нохияку Ко., Лтд. Фармацевтическая композиция для наружного применения
WO2010093992A1 (en) * 2009-02-13 2010-08-19 Topica Pharmaceuticals, Inc Anti-fungal formulation
WO2011155640A1 (en) * 2010-06-11 2011-12-15 Pola Pharma Inc. Antimycotic pharmaceutical composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2847436C2 (ru) * 2022-03-18 2025-10-03 Нихон Нохияку Ко., Лтд. Соединение азола и противогрибковый агент

Also Published As

Publication number Publication date
IN2015DN02930A (enExample) 2015-09-18
JP2014058449A (ja) 2014-04-03
RU2015113587A (ru) 2016-11-10
JP5460797B1 (ja) 2014-04-02
US9145401B2 (en) 2015-09-29
EP2895480A1 (en) 2015-07-22
WO2014041825A1 (en) 2014-03-20
CN104662017A (zh) 2015-05-27
US20150191456A1 (en) 2015-07-09

Similar Documents

Publication Publication Date Title
US9145401B2 (en) Amide derivative and use of the same as stability index of a luliconazole pharmaceutical formulation
RU2621615C2 (ru) Фармацевтическая композиция, содержащая луликоназол
KR101343291B1 (ko) 외용의 의약 조성물
RU2419429C2 (ru) Фармацевтическая композиция для наружного применения
TWI316857B (en) Topical composition
JP5654497B2 (ja) 抗真菌製剤
US20090076109A1 (en) Pharmaceutical Composition for External Use
CA2799928A1 (en) Topical formulation for a jak inhibitor
CA3159633A1 (en) Mrgprx2 antagonists and uses thereof
CN109475555A (zh) Pde-4抑制剂的局部配制品以及它们的使用方法
JP5587488B1 (ja) ルリコナゾールを含有する製剤の評価方法及び指標物質
CA3174475A1 (en) Topical pharmaceutical formulations of a cyclic depsipeptide
JP5623671B1 (ja) ルリコナゾールを含有する製剤の評価方法及び指標物質
JP5722364B2 (ja) 医薬組成物
JP2007106736A (ja) 注射用の医薬組成物
JP6067399B2 (ja) 医薬組成物
KR20170137117A (ko) 피부용의 의약 조성물
JP2015113341A (ja) ルリコナゾールを含有する製剤の評価方法及び指標物質